Parnassus Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,337,970
Closed -$154M 143
2023
Q2
$154M Sell
1,337,970
-593,737
-31% -$67.4M 0.36% 58
2023
Q1
$206M Hold
1,931,707
0.51% 50
2022
Q4
$214M Sell
1,931,707
-374,841
-16% -$38.3M 0.53% 48
2022
Q3
$199M Hold
2,306,548
0.52% 52
2022
Q2
$210M Hold
2,306,548
0.5% 50
2022
Q1
$189M Hold
2,306,548
0.38% 56
2021
Q4
$177M Buy
2,306,548
+349,615
+18% +$27.8M 0.34% 63
2021
Q3
$147M Buy
1,956,933
+249,631
+15% +$19M 0.31% 64
2021
Q2
$133M Buy
+1,707,302
New +$127M 0.29% 74

Other funds holding MRK

Parnassus Investments's MRK Position: Q3 2023 in Review

Parnassus Investments sold out of Merck (MRK) in Q3 2023, closing a stake of 1,337,970 shares — an estimated $154M sold.

Parnassus Investments first reported a position in MRK in Q2 2021 and held it in 9 quarters. The position peaked at $214M in Q4 2022. 3,215 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Parnassus Investments reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Parnassus Investments sold 1,337,970 Merck shares in Q3 2023, an estimated $154M.
  • Parnassus Investments first reported a position in Merck in Q2 2021 and held it in 9 quarters.
  • Parnassus Investments's Merck position peaked at $214M in Q4 2022.
  • 3,215 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Parnassus Investments's 13F filing for Q3 2023, filed 8 Nov 2023.